Refine Results
  1. "Annals of Oncology"
Formats
  1. Meeting Abstract (342)
  2. Journal Article (281)
  3. Conference Paper (6)
Groups
  1. Solid Tumor Oncology Division (402)
  2. Genitourinary Oncology Service (129)
  3. Thoracic Malignancies Disease Management Team (98)
  4. Genitourinary Disease Management Team (92)
  5. Gastrointestinal Oncology Service (90)
  6. Breast Cancer Disease Management Team (85)

More Groups

People
  1. Robert Motzer (41)
  2. Clifford Hudis (29)
  3. Jedd Wolchok (28)
  4. Jose Baselga (27)
  5. Andrew Zelenetz (26)
  6. Howard Scher (24)

More People

Years
  1. 2019 (1)
  2. 2018 (51)
  3. 2017 (123)
  4. 2016 (94)
  5. 2015 (34)
  6. 2014 (39)

More Years

Publications
  1. Annals of Oncology (629)
Publishers
  1. Oxford University Press (629)

Results (629)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: Implications for immunotherapy
    Journal Article

    Chen, Y. P.; Wang, Y. Q.; Lv, J. W.; Li, Y. Q.; Chua, M. L. K.; Le, Q. T.; Lee, N.; Colevas, A. D.; Seiwert, T.; Hayes, D. N.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)
    Meeting Abstract

    Shitara, K.; Tabernero, J.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Yau, T.; Merle, P.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Harris, W. P.; Banu, E.; Sarker, D.; Tan, B.; van Vlierberghe, H.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data
    Meeting Abstract

    Sakai, H.; Felip, E.; Cortot, A. B.; Veillon, R.; Griesinger, F.; Patel, J.; Horn, L.; Mazieres, J.; De Castro Carpeno, J.; Morise, M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial
    Meeting Abstract

    Friedlander, M.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
    Meeting Abstract

    Tan, D. S. W.; Lassen, U. N.; Albert, C. M.; Kummar, S.; van Tilburg, C.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Basu-Mallick, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin plus gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) plus CIS plus GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer
    Meeting Abstract

    Oh, D. Y.; Park, J. O.; Charoentum, C.; Stein, S.; Noel, M.; Chung, V.; Wu, W.; Alton, R.; Muhsin, M.; Javle, M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp): A phase II trial in progress
    Meeting Abstract

    Paik, P.; Sakai, H.; Bruns, R.; Scheele, J.; Straub, J.; Felip, E.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Novel therapies in urothelial carcinoma: A biomarker-driven approach
    Journal Article

    Iyer, G.; Rosenberg, J. E.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant sunitinib in patients with high-risk renal cell carcinoma: Safety, therapy management, and patient-reported outcomes in the S-TRAC trial
    Journal Article

    Staehler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Pantuck, A. J.; Patel, A.; DeAnnuntis, L.; Bhattacharyya, H.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save